Molecular Research in Neurological and Psychiatric Disease Volume II

Dear Colleagues,

Neuropsychiatric disorders have complex etiologies and pathophysiology. Research on molecular biology of neurological and psychiatric diseases from the aspects of genomics, biomarkers and drug discovery provides applications for early detection and clinical treatment of diseases. Although many studies have focused on the molecular basis of neuropsychiatry disorder, there are still many aspects of prevention and treatment for neurological and psychiatric diseases that needs to be studied.

Currently, the biomarkers for many neuropsychiatric disorders are not fully understood, thus a study of potential biomarkers of neuropsychiatric diseases can be of great help to clinicians in the early diagnosis of diseases. Furthermore, understanding the molecular mechanisms of neuropsychiatric diseases can be used for the development of drugs. Thus, we cordially invite authors and investigators within this field, to submit articles pertaining to this Special Issue. 

In this Special Issue, we aim to publish original research and reviews articles in the area of: (1) the potential biomarkers; (2) the molecular mechanism; and (3) the intervention or treatment of neuropsychiatry disease. I am convinced that this Special Issue of Biomedicines will unveil the mechanisms of neurological and psychiatry diseases and inspire the development of potential therapies. I look forward to your contributions to this Special Issue.

Dr. Shioulan Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neurological disease
• psychiatric disease
• biomarker
• molecular mechanism